Detalhe da pesquisa
1.
Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics.
Proc Natl Acad Sci U S A
; 120(28): e2300590120, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399393
2.
Natural killer cell education and tolerance.
Cell
; 142(6): 847-56, 2010 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-20850008
3.
Co-development of implementation strategies to assist staff of a mental health community managed organisation provide preventive care for health behaviours.
Health Promot J Austr
; 2023 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821103
4.
'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection.
Nat Immunol
; 11(4): 321-7, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20190757
5.
Memory CD4+ T cells enhance B-cell responses to drifting influenza immunization.
Eur J Immunol
; 49(2): 266-276, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548475
6.
CD94 is essential for NK cell-mediated resistance to a lethal viral disease.
Immunity
; 34(4): 579-89, 2011 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21439856
7.
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
J Immunol
; 201(1): 98-112, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769270
8.
IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.
J Immunol
; 197(11): 4351-4359, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27794001
9.
Antigen presentation by B cells guides programing of memory CD4+ T-cell responses to a TLR4-agonist containing vaccine in mice.
Eur J Immunol
; 46(12): 2719-2729, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27701733
10.
Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic Mechanism.
J Immunol
; 195(7): 3190-7, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26297758
11.
Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.
Eur J Immunol
; 45(2): 407-17, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25367751
12.
Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.
J Immunol
; 193(6): 2911-8, 2014 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25086172
13.
Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.
J Infect Dis
; 212(3): 495-504, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25637347
14.
Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells.
J Immunol
; 191(5): 2514-2525, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23904160
15.
MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Eur J Immunol
; 43(9): 2398-408, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23716300
16.
Mass fatality preparedness among medical examiners/coroners in the United States: a cross-sectional study.
BMC Public Health
; 15: 1275, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25511819
17.
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.
J Infect Dis
; 207(8): 1242-52, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22891286
18.
Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET® CC-96191.
Cancers (Basel)
; 16(5)2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473239
19.
Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC.
Blood
; 117(26): 7032-41, 2011 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21498673
20.
Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirus.
Proc Natl Acad Sci U S A
; 107(36): 15844-9, 2010 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20733071